Gene · 6443
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fighting Post-COVID and ME/CFS - development of curative therapies. | Front Med (Lausanne) | 2023 | 37396922 | PubTator, text mining | PubMed |
| Metabolic reprogramming, oxidative stress, and pulmonary hypertension. | Redox Biol | 2023 | 37392518 | PubTator, text mining | PubMed |
Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study. | Front Cardiovasc Med | 2023 | 37383703 | PubTator, text mining | PubMed |
| Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs. | Pharmaceutics | 2023 | 37376028 | PubTator, text mining | PubMed |
| Insights into Endothelin Receptors in Pulmonary Hypertension. | Int J Mol Sci | 2023 | 37373355 | PubTator, text mining | PubMed |
| Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease. | Int J Mol Sci | 2023 | 37373103 | PubTator, text mining | PubMed |
| The spectrum of hereditary neuromuscular disorders in the Pakistani population. | Am J Med Genet A | 2023 | 37366078 | PubTator, text mining | PubMed |
| Pharmacological targeting of gastric mucosal barrier with traditional Chinese medications for repairing gastric mucosal injury. | Front Pharmacol | 2023 | 37361204 | PubTator, text mining | PubMed |
| YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia. | Blood Adv | 2023 | 37339496 | PubTator, text mining | PubMed |
| Who makes in-play bets? Investigating the demographics, psychological characteristics, and gambling-related harms of in-play sports bettors. | J Behav Addict | 2023 | 37335776 | PubTator, text mining | PubMed |
| Deciphering transcriptional dynamics of cardiac hypertrophy and failure in a chamber-specific manner. | Biomol Biomed | 2023 | 37334749 | PubTator, text mining | PubMed |
| The role of monocytes in thrombotic diseases: a review. | Front Cardiovasc Med | 2023 | 37332592 | PubTator, text mining | PubMed |
| Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets. | Front Cardiovasc Med | 2023 | 37332581 | PubTator, text mining | PubMed |
| Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment. | BMC Neurol | 2023 | 37328820 | PubTator, text mining | PubMed |
| Removing uncertainty from variants of unknown significance. | J Clin Invest | 2023 | 37317969 | PubTator, text mining | PubMed |
| Comprehensive functional characterization of SGCB coding variants predicts pathogenicity in limb-girdle muscular dystrophy type R4/2E. | J Clin Invest | 2023 | 37317968 | PubTator, text mining | PubMed |
| [Soluble guanylate cyclase: restoration of the NO-sGC-cGMP signaling pathway activity. A new opportunity in the treatment of heart failure]. | Kardiologiia | 2023 | 37307211 | PubTator, text mining | PubMed |
| MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. | Int J Mol Sci | 2023 | 37298685 | PubTator, text mining | PubMed |
| Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm. | Int J Mol Sci | 2023 | 37298225 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6443/papers?page=11